[Gynecomastia during long term treatment of Cushing's disease with OP'DDD].
D003480:Cushing Syndrome / Q000188:drug therapy*; D003632:Dichlorodiphenyldichloroethane / Q000009:adverse effects*; D004967:Estrogens / Q000378:metabolism / Q000652:urine; D005260:Female; D006177:Gynecomastia / Q000139:chemically induced* / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008297:Male; D013237:Stereoisomerism; D013739:Testosterone / Q000097:blood
D004967:Estrogens; D013739:Testosterone; D003632:Dichlorodiphenyldichloroethane; D006854:Hydrocortisone
Gynécomasties au cours de traitements prolongés de la maladie de Cushing par l'OP'DD.